Ligandrol - Driada Medical

Originally intended to address muscle degeneration, Ligandrol (LGD-4033) was synthesized by Ligand Pharmaceuticals in the early 2010s. This SARM was designed to selectively stimulate androgen receptors in muscle and bone, mimicking the anabolic effects of steroids without severe androgenic impact. While it has gained traction in fitness and bodybuilding for its muscle-preserving properties, LGD-4033 remains a research chemical under ongoing evaluation for its long-term safety and efficacy, lacking formal medical approval.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Ligandrol by Driada Medical, consult with your doctor or healthcare professional.